Aarti Pharmalabs Ltd Share Price
(AARTIPHARM)
₹735.15
as on 04:01PM, 25 Apr 2025
Aarti Pharmalabs Ltd Performance
Day's Low
Day's High
₹718Day's Price Range₹764.452 Week's Low
52 Week's High
₹487.8552-Week Price Range₹837.25
| Returns % | |
| 1 Month Return | + 4.13 % |
| 3 Month Return | + 26.27 % |
| 1 Year Return | + 41.75 % |
| Market Stats | |
| Previous Close | ₹753.90 |
| Open | ₹753.90 |
| Volume | 2.89L |
| Upper Circuit | ₹904.65 |
| Lower Circuit | ₹603.15 |
| Market Cap | ₹6,832.94Cr |
Aarti Pharmalabs Ltd Fundamentals
P/E Ratio
27.4
PEG Ratio
4.54
Market Cap
₹6,832.94 Cr
P/B Ratio
2.43
EPS
23.93
Dividend Yield
0.69
Sector
Pharmaceuticals
ROE
13.11
Mutual Fund Holdings of Aarti Pharmalabs Ltd
Key events for Aarti Pharmalabs Ltd
Aarti Pharmalabs Reports Strong Q3 Growth - 18 Apr, 2025
Aarti Pharmalabs' stock increased by 2.3% to Rs. 733.9, supported by a 20% YoY revenue growth to Rs. 538 crores and a 40% rise in net profit.Aarti Pharmalabs Achieves SBTi Emission Targets Approval - 16 Apr, 2025
Aarti Pharmalabs has received official approval from the Science Based Targets initiative for its emission reduction goals across all scopes, marking a significant commitment to sustainability. This achievement aligns with the Paris Agreement and enhances the company's appeal to environmentally focused partners.Aarti Pharmalabs Forms Joint Venture with Ganesh Polychem - 01 Apr, 2025
Aarti Pharmalabs Limited has established a joint venture with Ganesh Polychem Limited, effective March 31, 2025. This strategic partnership aims to enhance operational capabilities and market positioning, with consolidated financial statements to be prepared using the equity method. The collaboration is expected to drive innovation and business expansion in the pharmaceutical sector.
Insights on Aarti Pharmalabs Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 2 quarters, 462.51 Cr → 542.81 Cr (in ₹), with an average increase of 14.8% per quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, 54.62 Cr → 73.99 Cr (in ₹), with an average increase of 26.2% per quarter
- POSITIVE IMPACT
Price Rise
In the last 3 months, AARTIPHARM stock has moved up by 26.3%
- POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 36.33% to 40.81% in Mar 2025 quarter
NEGATIVE IMPACTFII Holding Down
Foreign Institutions have decreased holdings from 8.64% to 7.36% in Mar 2025 quarter
- NEGATIVE IMPACT
MF Holding Down
Mutual Funds have decreased holdings from 3.93% to 0.78% in Mar 2025 quarter
- NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 44.66% to 44.29% in Mar 2025 quarter
Aarti Pharmalabs Ltd Financials
Aarti Pharmalabs Ltd Index Inclusions
Aarti Pharmalabs Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 44.29% | 0.00 | |
| Foreign Institutions | 7.36% | 0.00 | |
| Mutual Funds | 0.78% | 0.00 | |
| Retail Investors | 40.81% | 0.00 | |
| Others | 6.76% | 0.00 |
Aarti Pharmalabs Ltd Key Indicators
Aarti Pharmalabs Ltd Valuation
Aarti Pharmalabs Ltd in the last 5 years
Lowest (11.23x)
February 2, 2023
Today (27.40x)
April 24, 2025
Industry (54.50x)
April 24, 2025
Highest (29.40x)
February 18, 2025
Aarti Pharmalabs Ltd Earnings and Dividends
Aarti Pharmalabs Ltd Earnings Results
Aarti Pharmalabs Ltd’s net profit jumped 40.24% since last year same period to ₹73.99Cr in the Q3 2024-2025. On a quarterly growth basis, Aarti Pharmalabs Ltd has generated 35.46% jump in its net profits since last 3-months.
Read More about Earnings ResultsAarti Pharmalabs Ltd Dividends February,2025
In the quarter ending December 2024, Aarti Pharmalabs Ltd has declared dividend of ₹2.50 - translating a dividend yield of 0.75%.
Read More about Dividends
Aarti Pharmalabs Ltd Technicals Summary
Bearish
Neutral
Bullish
Aarti Pharmalabs Ltd is currently in a Bullish trading position according to technical analysis indicators.
Aarti Pharmalabs Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹6,832.94 Cr | 32.31% | 0.57 | ₹216 Cr | ₹1,852 Cr | |
| NA | ₹23,807.39 Cr | 99.06% | 0.77 | -₹472 Cr | ₹2,798 Cr | |
| BUY | ₹5,686.91 Cr | 16.16% | 0.50 | NA | NA | |
| NA | ₹907.28 Cr | 222.86% | 0.91 | ₹55 Cr | ₹575 Cr | |
| NA | ₹155.78 Cr | 98.93% | 0.69 | NA | NA |
About Aarti Pharmalabs Ltd
Revenue: ₹537.78Cr as on December 2024 (Q4 24)
Net Profit: ₹73.99Cr as on December 2024 (Q4 24)
Listing date: 30 Jan, 2023
Chairperson Name: Rashesh C Gogri
| Organisation | Aarti Pharmalabs Ltd |
| Headquarters | Mumbai |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
FAQs on Aarti Pharmalabs Ltd
What is Aarti Pharmalabs Ltd price today?
Aarti Pharmalabs Ltd share price today stands at ₹735.15, Open: ₹753.9, Previous Close: ₹753.9, High: ₹764.4, Low: ₹718, 52 Week High: ₹837.25, 52 Week Low: ₹487.85.
How to Buy Aarti Pharmalabs Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy Aarti Pharmalabs Ltd shares
What are today's traded volumes of Aarti Pharmalabs Ltd?
Today's traded volume of Aarti Pharmalabs Ltd(AARTIPHARM) is 2.89L.
What is today's market capitalisation of Aarti Pharmalabs Ltd?
Today's market capitalisation of Aarti Pharmalabs Ltd(AARTIPHARM) is ₹6832.94Cr.
What is the 52 Week High and Low Range of Aarti Pharmalabs Ltd?
How much percentage Aarti Pharmalabs Ltd is down from its 52 Week High?
Aarti Pharmalabs Ltd (AARTIPHARM) share price is ₹735.15. It is down -12.19% from its 52 Week High price of ₹837.25
How much percentage Aarti Pharmalabs Ltd is up from its 52 Week low?
Aarti Pharmalabs Ltd (AARTIPHARM) share price is ₹735.15. It is up 50.69% from its 52 Week Low price of ₹487.85